This screening tool can be used by healthcare practitioners to help determine whether an individual may receive a shingles vaccine and to identify the most suitable shingles vaccine to administer based on any pre-existing medical conditions.

There are two licensed shingles vaccines available in the UK. Some individuals who are eligible for vaccination but contraindicated to Zostavax®, due to conditions that result in severe immunosuppression, may be indicated for the non-live shingles vaccine (Shingrix®).

A clinical risk assessment should be undertaken to identify individuals who are severely immunosuppressed and the administration of Shingrix® can then be considered.

General enquiries

If you have an enquiry relating to this publication, please email phs.immunisation@phs.scot.

Media enquiries

If you have a media enquiry relating to this publication, please contact the Communications and Engagement team.

Requesting other formats and reporting issues

If you require publications or documents in other formats, please email phs.otherformats@phs.scot.

To report any issues with a publication, please email phs.generalpublications@phs.scot.

Last updated: 26 November 2021
Was this page helpful?